Clinical trial
Repositioning Ivermectin for the Treatment of Alcohol Use Disorders
NCT02046200 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repositioning Ivermectin for the Treatment of Alcohol Use Disorders
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- March 31, 2015
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder